Baby’s 1st Christmas Event

Community NewsNews
382

Translate to Spanish or other 102 languages!

Courtesy Image

Mega Doctor News

- Advertisement -

EDINBURG – Precinct 4, in partnership with Texas A&M University Colonias Program and Driscoll Health Plan will be hosting “Baby’s 1st Christmas” on Friday, December 10, 2021 from 9:00 am until 11:00 am at the Pct. 4 Endowment Center located at 107 N. Sunflower Road in Edinburg.

Courtesy Image

Expectant mothers or parents with children under the age of 8 months may attend the event. Please bring a sonogram or baby’s picture to make a special ornament. Face masks are highly recommended.

Health education sessions will be conducted on several topics that include infant immunizations, lactation techniques, and other health topics for infant care.  

- Advertisement -

“It brings me great joy to have so many great organizations come together at the Endowment Center to share a wealth of knowledge with first-time parents.  It takes a village to raise a child and we need to do our part in the county to help parents learn about health and safety for their children,” stated Precinct 4 Commissioner Ellie Torres. 

For more information, please contact the Hidalgo County Precinct 4 Endowment Center at (956) 289-7429. 

Hidalgo County Commissioner Ellie Torres, Precinct 4

Baby’s 1st Christmas Event

- Advertisement -

9:00 a.m. – 11:00 a.m., Friday, December 10, 2021

107 N. Sunflower Road, Edinburg, TX

For questions or concerns regarding this event please call 956-289-7429.

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
FREE Health and Wellness Fairs for the public
Next article
Post Pandemic Obesity Posing a New Challenge

More Articles

STHS Dedicating Latest “South Texas Healthy Living” Episode to Arthritis Education, July 26th

More than 58 million U.S. adults are living with doctor-diagnosed arthritis, according to the Centers for Disease Control and Prevention (CDC), making it the nation’s leading cause of disability.

No More Needles: FDA Approves First Daily Pill to Replace Injectable Cholesterol Drugs

The U.S. Food and Drug Administration approved Lipfendra (enlicitide), the first oral inhibitor of proprotein convertase subtilisin/kexin type 9 (PCSK9), as an adjunct to diet and exercise to reduce low-density lipoprotein cholesterol (LDL-C), or “bad” cholesterol, in adults with hypercholesterolemia, including those with heterozygous familial hypercholesterolemia (HeFH). Image source: Merck.com.

STHS Heart Ranks Among Nation’s Top Hospitals for Heart Attack Care

Every year, more than 800,000 people in the United States suffer a heart attack, according to the Centers for Disease Control and Prevention, an event that occurs approximately every 40 seconds.

DHR Health Burn Surgeon Urges Public to Avoid Preventable Risks

Many of the most serious burn and trauma injuries can be prevented by avoiding unnecessary risks, according to Dr. R. Dewayne Edwards, chief burn surgeon, surgical critical care and trauma surgeon at DHR Health, who said public awareness and timely medical care remain essential to improving patient outcomes.
- Advertisement -